Back to Journals » Biologics: Targets and Therapy » Volume 1 » Issue 1

First line targeted therapies in breast cancer: focus on bevacizumab || FREE PAPER ||

         
Total article views   Abstract views HTML views PDF downloads Totals
5,830 Dovepress* 5,830 0+ 1,887 5,830
Totals 5,830 0 1,887 5,830
*Since 15 August 2007
+Since July 2016

View citations on Google Scholar